Olwyn Kendrick: Difference between revisions
m edit link |
No edit summary |
||
| Line 9: | Line 9: | ||
| relations = | | relations = | ||
}} | }} | ||
'''Olwyn Kendrick''' is the CEO of [[Neomedical Industries]]. In August 3307, he | '''Olwyn Kendrick''' is the CEO of [[Neomedical Industries]]. In August 3307, he announced plans for his company to manufacture [[Onionhead Gamma Strain]] for the mass market in response to an [[Interstellar Health Organisation]] report authored by Dr. [[Nisha Devi]] indicating the drug has medical benefits. Kendrick believed that it was inappropriate to allow the criminal syndicate [[Kumo Crew]], the original producer of Onionhead Gamma Strain, to be the drug's sole producer. | ||
{{clr}} | {{clr}} | ||
== Timeline == | == Timeline == | ||
30 AUG 3307 | 30 AUG 3307 | ||
*The pharmaceutical giant Neomedical Industries aims to mass-produce onionhead gamma strain as a medicine. | *The pharmaceutical giant [[Neomedical Industries]] aims to mass-produce [[Onionhead Gamma Strain|onionhead gamma strain]] as a medicine. The announcement follows a report from the [[Interstellar Health Organisation]], which details how the new onionhead variant is an effective treatment for many psychological and musculoskeletal conditions. Olwyn Kendrick, CEO of Neomedical Industries, told the media: "The IHO has confirmed the findings of our research of onionhead gamma strain's use for specific medical purposes. Clinical trials prove that its psychedelic qualities are no more intense than the side effects of conventional neuroleptics. It is inappropriate that a crime syndicate should provide a product that can relieve the suffering of millions. Therefore, we aim to build our own stockpile to expedite its distribution to common markets." This statement was viewed as controversial in some quarters, particularly within the [[Federation]]. However, there have been expressions of interest from many [[independent]] factions. The [[Kumo Crew]] syndicate, which manufactures and distributes onionhead gamma strain, has offered no response as yet. Neomedical Industries is one of the two largest pharmaceutical companies in the galaxy, alongside [[Vandermeer Corporation]]. It provides healthcare services and equipment exclusively to [[Alliance]] and independent systems.<ref>[https://community.elitedangerous.com/galnet/uid/6128e5720c9cdf4338166e23 GalNet: Corporation Plans Onionhead Medical Product]</ref> | ||
The announcement follows a report from the Interstellar Health Organisation, which details how the new onionhead variant is an effective treatment for many psychological and musculoskeletal conditions. | |||
Olwyn Kendrick, CEO of Neomedical Industries, told the media: | |||
This statement was viewed as controversial in some quarters, particularly within the Federation. However, there have been expressions of interest from many independent factions. The Kumo Crew syndicate, which manufactures and distributes onionhead gamma strain, has offered no response as yet. | |||
Neomedical Industries is one of the two largest pharmaceutical companies in the galaxy, alongside Vandermeer Corporation. It provides healthcare services and equipment exclusively to Alliance and independent systems. | |||
<ref>[https://community.elitedangerous.com/galnet/uid/6128e5720c9cdf4338166e23 GalNet: Corporation Plans Onionhead Medical Product]</ref> | |||
== References == | == References == | ||
Revision as of 02:35, 31 August 2021
Olwyn Kendrick is the CEO of Neomedical Industries. In August 3307, he announced plans for his company to manufacture Onionhead Gamma Strain for the mass market in response to an Interstellar Health Organisation report authored by Dr. Nisha Devi indicating the drug has medical benefits. Kendrick believed that it was inappropriate to allow the criminal syndicate Kumo Crew, the original producer of Onionhead Gamma Strain, to be the drug's sole producer.
Timeline
30 AUG 3307
- The pharmaceutical giant Neomedical Industries aims to mass-produce onionhead gamma strain as a medicine. The announcement follows a report from the Interstellar Health Organisation, which details how the new onionhead variant is an effective treatment for many psychological and musculoskeletal conditions. Olwyn Kendrick, CEO of Neomedical Industries, told the media: "The IHO has confirmed the findings of our research of onionhead gamma strain's use for specific medical purposes. Clinical trials prove that its psychedelic qualities are no more intense than the side effects of conventional neuroleptics. It is inappropriate that a crime syndicate should provide a product that can relieve the suffering of millions. Therefore, we aim to build our own stockpile to expedite its distribution to common markets." This statement was viewed as controversial in some quarters, particularly within the Federation. However, there have been expressions of interest from many independent factions. The Kumo Crew syndicate, which manufactures and distributes onionhead gamma strain, has offered no response as yet. Neomedical Industries is one of the two largest pharmaceutical companies in the galaxy, alongside Vandermeer Corporation. It provides healthcare services and equipment exclusively to Alliance and independent systems.[1]